Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Active Immunotherapy with Globo H-KLH (OPT-822) in Metastatic Breast Cancer
KCT0000707Phase 3Active, not recruiting
- Sponsor
- Choice Pharma
- Start
- Jan 2013
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adagloxad simolenin in breast cancer, sponsored by Choice Pharma. Started Jan 2013; status: active, not recruiting.
02
Drugs
adagloxad simolenin
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0000707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000707.